跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,288 条关于
“papillary carcinoma”
全部
21,288
临床试验
19,300
药物
99
机构
2
资讯
1,887
去年
Cabozantinib Fails to Show Overall Survival Benefit in Papillary Renal Cell Carcinoma
2个月前
Vivos Receives FDA IDE Approval for First-in-Human RadioGel Trial in Non-Resectable Papillary Thyroid Carcinoma
去年
Bevacizumab-Erlotinib Combination Shows Remarkable 72% Response Rate in Rare HLRCC-Associated Kidney Cancer
3个月前
Vivos Inc. Receives FDA IDE Approval to Initiate First-in-Human Study of RadioGel® for Papillary Thyroid Carcinoma
去年
BRAF p.V600E Mutation Shows Limited Prognostic Value in Papillary Thyroid Cancer Risk Stratification
24天前
PathNet Expands Urologic Pathology Offerings with In-House PTEN and FGFR3 Biomarker Testing
2年前
Lenvatinib and Pembrolizumab Combination Shows Promise in Non-Clear Cell Renal Cell Carcinoma Subtypes
去年
FDA Requests Additional Manufacturing Data for Telix's Kidney Cancer Diagnostic Drug Zircaix
去年
UK Phase III Trial Shows Low-Risk Thyroid Cancer Patients Can Safely Skip Radioiodine Ablation After Surgery
去年
TAR-210 Shows Promise in FGFR-Altered Non-Muscle Invasive Bladder Cancer
第 1 页,共 189 页
上一页
下一页